Art. 2 Inwerkingtreding : 18-02-2000>
a) BROLAMFETAMINE (DOB);
CATHINONE;
DET (3-(2-(diethylamino)ethyl)indole);
DMA ((+)-2,5-dimethoxy-alpha-methylphenethylamine);
DMHP (3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-ol);
DMT (3-(2-(dimethylamino)ethyl)indole);
DOET ((+)-4-ethyl-2,5-dimethoxy-alpha-phenethylamine);
ETICYCLIDINE (PCE);
ETRYPTAMINE;
(+)-LYSERGIDE (LSD, LSD-25);
MDMA ((+)-N,alpha-dimethyl-3,4-(methylenedioxy)phenethylamine);
MESCALINE (3,4,5-trimethoxyphenethylamine);
METHCATHINONE (methylamino-2-phenylpropaan-1-on);
4-METHYLAMINOREX ((+)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline);
MMDA (2-methoxy-alpha-methyl-4,5-(methylenedioxy)phenethylamine);
N-ETHYL MDA ((+)-N-ethyl-alpha-methyl-3,4-(methylenedioxy)phenethylamine);
N-HYDROXY MDA ((+)-N-(alpha-methyl-3,4-(methylenedioxy)phenethyl)hydroxylamine);
PARAHEXYL (3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-ol);
PMA (p-methoxy-alpha-methylphenethylamine);
PSILOCINE (psilotsin of 3-(2-(dimethyl-amino)ethyl)indol-4-ol);
PSILOCYBINE;
ROLICYCLIDINE (PHP, PCPY);
STP (DOM);
TENAMFETAMINE (MDA);
TENOCYCLIDINE (TCP);
TETRAHYDROCANNABINOL, volgende isomeren en hun stereochemische varianten :
- 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d)pyran-1-ol;
- (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- 6a,7,8,9,-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
TMA ((+)-3,4,5-trimethoxy-alpha-methylphenethylamine);
b) AMFETAMINE;
(AMINEPTINE) <KB 2004-10-18/31, art. 1, 006; Inwerkingtreding : 18-11-2004>
DELTA-9-TETRAHYDROCANNABINOL en zijn stereochemische varianten ((6aR,10aR)-6a, 7,8,10a,-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol);
DEXAMFETAMINE;
FENETYLLINE;
LEVAMFETAMINE;
LEVOMETAMFETAMINE;
MECLOQUALONE;
METAMFETAMINE;
METAMFETAMINE RACEMAAT;
METHAQUALONE;
METHYLPHENIDATE;
PHENCYCLIDINE (PCP);
PHENMETRAZINE;
SECOBARBITAL;
ZIPEPROL.
(<2>-<CB>) <KB 2002-04-30/33, art. 1, 004; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
AMFEPRAMONE;
(BZP of 1-BENZYLPIPERAZINE) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
CLOBENZOREX;
DIPROPYLTRYPTAMINE;
ETILAMFETAMINE;
FENPROPOREX;
(FLUNITRAZEPAM) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
FURFENOREX;
GHB (gamma hydroxyboterzuur);
IBOGAINE;
KETAMINE;
MBDB (N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine);
MEFENOREX;
(4-MTA) <KB 1999-11-16/39, art. 1, 002; Inwerkingtreding : Inwerkingtreding : Inwerkingtreding : Inwerkingtreding : 16-12-2006>
(TMA-2 of 2,4,5-trimethoxyamphetamine <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(TFMPP of 1-(3-TRIFLUOROMETHYLPHENYL) PIPERAZINE <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-I of 2,5-dimethoxy-4-iodophenethylamine) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-T-2 " of " 2,5-dimethoxy-4-ethylthiophenethylamine) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-T-7 of 2,5-dimethoxy-4-(n)-propylthiophenethylamine <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
Uitgebreider
a) BROLAMFETAMINE (DOB);
CATHINONE;
DET (3-(2-(diethylamino)ethyl)indole);
DMA ((+)-2,5-dimethoxy-alpha-methylphenethylamine);
DMHP (3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-ol);
DMT (3-(2-(dimethylamino)ethyl)indole);
DOET ((+)-4-ethyl-2,5-dimethoxy-alpha-phenethylamine);
ETICYCLIDINE (PCE);
ETRYPTAMINE;
(+)-LYSERGIDE (LSD, LSD-25);
MDMA ((+)-N,alpha-dimethyl-3,4-(methylenedioxy)phenethylamine);
MESCALINE (3,4,5-trimethoxyphenethylamine);
METHCATHINONE (methylamino-2-phenylpropaan-1-on);
4-METHYLAMINOREX ((+)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline);
MMDA (2-methoxy-alpha-methyl-4,5-(methylenedioxy)phenethylamine);
N-ETHYL MDA ((+)-N-ethyl-alpha-methyl-3,4-(methylenedioxy)phenethylamine);
N-HYDROXY MDA ((+)-N-(alpha-methyl-3,4-(methylenedioxy)phenethyl)hydroxylamine);
PARAHEXYL (3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran-1-ol);
PMA (p-methoxy-alpha-methylphenethylamine);
PSILOCINE (psilotsin of 3-(2-(dimethyl-amino)ethyl)indol-4-ol);
PSILOCYBINE;
ROLICYCLIDINE (PHP, PCPY);
STP (DOM);
TENAMFETAMINE (MDA);
TENOCYCLIDINE (TCP);
TETRAHYDROCANNABINOL, volgende isomeren en hun stereochemische varianten :
- 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d)pyran-1-ol;
- (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- 6a,7,8,9,-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
- (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo(b,d)pyran-1-ol;
TMA ((+)-3,4,5-trimethoxy-alpha-methylphenethylamine);
b) AMFETAMINE;
(AMINEPTINE) <KB 2004-10-18/31, art. 1, 006; Inwerkingtreding : 18-11-2004>
DELTA-9-TETRAHYDROCANNABINOL en zijn stereochemische varianten ((6aR,10aR)-6a, 7,8,10a,-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol);
DEXAMFETAMINE;
FENETYLLINE;
LEVAMFETAMINE;
LEVOMETAMFETAMINE;
MECLOQUALONE;
METAMFETAMINE;
METAMFETAMINE RACEMAAT;
METHAQUALONE;
METHYLPHENIDATE;
PHENCYCLIDINE (PCP);
PHENMETRAZINE;
SECOBARBITAL;
ZIPEPROL.
(<2>-<CB>) <KB 2002-04-30/33, art. 1, 004; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
AMFEPRAMONE;
(BZP of 1-BENZYLPIPERAZINE) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
CLOBENZOREX;
DIPROPYLTRYPTAMINE;
ETILAMFETAMINE;
FENPROPOREX;
(FLUNITRAZEPAM) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
FURFENOREX;
GHB (gamma hydroxyboterzuur);
IBOGAINE;
KETAMINE;
MBDB (N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine);
MEFENOREX;
(4-MTA) <KB 1999-11-16/39, art. 1, 002; Inwerkingtreding : Inwerkingtreding : Inwerkingtreding : Inwerkingtreding : 16-12-2006>
(TMA-2 of 2,4,5-trimethoxyamphetamine <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(TFMPP of 1-(3-TRIFLUOROMETHYLPHENYL) PIPERAZINE <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-I of 2,5-dimethoxy-4-iodophenethylamine) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-T-2 " of " 2,5-dimethoxy-4-ethylthiophenethylamine) <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : 18-11-2004>
(2C-T-7 of 2,5-dimethoxy-4-(n)-propylthiophenethylamine <KB 2004-10-18/31, art. 2, 006; Inwerkingtreding : Inwerkingtreding : 16-12-2006>
Uitgebreider
Comment